ACI’s upcoming due diligence conference promises to provide a “Complete Guide to M&As, Licensing, and Other Collaborations for the Pharmaceutical, Biotechnology and Medical Device Industries”. The event is set for Wednesday, January 20 and Thursday, January 21, 2010 in New York. If you work in the area, attending this conference deserves some serious consideration.
The ACI Program has a great line-up with a number of my favorite speakers on IP issues (including, in no particular order, Mercedes Meyer, John Li (of Novartis), and Bruce Pokras (“Mr. Orange Book”)). The program covers nearly every aspect of the IP diligence process, which is more important than ever in these tough economic times. A detailed Agenda identifying other great speakers and sessions can be found here – http://www.americanconference.com/diligence/agenda.htm.
